Danish pharmaceutical giant Novo Nordisk posted bumper profits for 2023 on Wednesday, driven by blockbuster sales of diabetes and obesity treatments that helped it become Europe's most valuable company.
Jan 31, 2024
0
0
Danish drugmaker Novo Nordisk reported Thursday a sharp rise in third quarter sales and profits driven by the success of its anti-diabetes and anti-obesity treatments Ozempic and Wegovy.
Nov 2, 2023
0
0
Anglo-Swedish drugmaker AstraZeneca on Thursday posted surging annual net profit, boosted by cancer treatments and the integration of biotech unit Alexion following a blockbuster takeover.
Feb 9, 2023
0
2
British pharmaceutical giant GlaxoSmithKline on Wednesday announced soaring annual profits thanks to the demerger of its consumer healthcare unit Haleon.
Feb 1, 2023
0
2
Production has been halted in the world's biggest chocolate plant, run by Swiss giant Barry Callebaut in the Belgian town of Wieze, after salmonella contaminations were found, the firm said Thursday.
Jun 30, 2022
0
11
Plastic surgeons play an key as consultants in complex reconstructive surgery cases—providing a major contribution to the bottom line for academic medical centers, concludes an analysis in the April issue of Plastic and ...
Mar 31, 2022
0
2
German vaccine-maker BioNTech on Wednesday reported a multi-billion-euro windfall in 2021 from sales of its anti-coronavirus jab, developed together with US pharmaceutical giant Pfizer.
Mar 30, 2022
0
8
British pharmaceuticals giant AstraZeneca said Thursday that its COVID jab generated $1.2 billion (1.0 billion euros) in sales in the first half of the year as global vaccination programmes accelerated.
Jul 29, 2021
0
123
Swiss pharmaceutical firm Roche said Thursday that drug sales have begun to recover from a COVID-induced slump as it confirmed forecasts for a modest increase in sales for the year as a whole.
Jul 22, 2021
0
1
British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company's performance in the face ...
Apr 30, 2021
0
5
